• 1
    Tajiri Y, Kato T, Nakyama H, Yamada K. Reduction of skeletal muscle, especially in lower limbs in Japanese type 2 diabetic patients with insulin resistance and cardiovascular risk factors. Metab Syndr Relat Disorders 2010; 8: 137-142.
  • 2
    Park SW, Goodpaster BH, Strotmeyer ES, et al. Accelerated loss of skeletal muscle strength in adults with type 2 diabetes: The health, aging, and body composition study. Diabetes Care 2007; 30: 1507-1512.
  • 3
    McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 6628: 83-90.
  • 4
    Gonzalez-Cadavid N, Taylor WE, Yarasheki KE, Sinha-Hikim I, Ma K, Ezzat S. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci USA 1998; 95: 14938-14943.
  • 5
    Hittel DS, Berggren JR, Shearer J, Boyle K, Houmard JA. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes 2009; 58: 30-38.
  • 6
    Allen DL, Cleary AS, Speaker KJ, et al. Myostatin, activin receptor IIb and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab 2008; 294: E918-E927.
  • 7
    Guo T, Jou W, Chanturiya T, Portas J, Gavrilova O, McPherron AC. Myostatin inhibition of muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 2009; 4: e4937.
  • 8
    Wilkes JJ, Llyod DJ, Gekakis N. Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes 2009; 58: 1133-1143.
  • 9
    Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 2002; 277: 49831-49840.
  • 10
    de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett 2008; 582: 97-105.
  • 11
    Muniyappa R, Lee S, Chen H, Quon MJ. Current approach for assessing insulin sensitivity and resistance in vivo: Advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008; 294: E15-E16.
  • 12
    Friedman JE, Ishizuka T, Shao J, Huston L, Highman T, Catalano P. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 1999; 48: 1807-1814.
  • 13
    Derde S, Herman G, Derese I, et al. Muscle atrophy and preferential loss of myosin in prolonged critically ill patients. Crit Care Med 2012; 40: 79-89.
  • 14
    Liu D, Black BL, Derynck R. TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev 2001; 15: 2950-2966.
  • 15
    Pfeiffer A, Middelberg-Bisping K, Drewes C, Schatz H. Elevated plasma levels of transforming growth factor-beta 1 in NIDDM. Diabetes Care 1996; 19: 1113-1117.